Literature DB >> 26581713

Improving the management of gastrointestinal bleeding in patients with cirrhosis.

Michael J Williams1, Peter Hayes1.   

Abstract

Gastrointestinal bleeding remains a major cause of mortality in patients with cirrhosis. The most common source of bleeding is from gastroesophageal varices but non-variceal bleeding from peptic ulcer disease also carries a significant risk in patients with liver disease. The prognosis is related to the severity of the underlying liver disease, and deaths often occur due to liver failure, infection or renal failure. Optimal management should therefore not only achieve haemostasis but address these complications as well. The management of gastrointestinal bleeding in patients with cirrhosis includes a range of medical, endoscopic and radiological interventions. This article updates the recent developments in this area and highlights topics where further research is still required.

Entities:  

Keywords:  Gastrointestinal bleeding; antibiotics; band ligation; cirrhosis; injection therapy; portal hypertension; transjugular intrahepatic portosystemic shunt (TIPSS); varices; vasoactive drugs

Mesh:

Substances:

Year:  2015        PMID: 26581713     DOI: 10.1586/17474124.2016.1122523

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  4 in total

1.  Clinical characteristics of cirrhosis patients with umbilical vein recanalization: A retrospective analysis.

Authors:  Qing Shi; Kai Xiong; Bin Ding; XiaoLing Ye
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

2.  The role of refined nursing combined with targeted nursing in patients with digestive tract hemorrhages complicated by liver cirrhosis.

Authors:  Yan Wang; Yanna Wang; Junping Han
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Effects of Vitamin C Combined with Growth Inhibitors on Gastrointestinal Bleeding in Cirrhosis.

Authors:  Shimei Wang; Yuanyuan Peng
Journal:  Contrast Media Mol Imaging       Date:  2022-07-18       Impact factor: 3.009

4.  Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.

Authors:  Dengke Teng; Hao Zuo; Lin Liu; Jinghui Dong; Lei Ding
Journal:  Virol J       Date:  2018-10-01       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.